- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-20-0059628

About Celera Pharma Private Limited
Data last updated:
Celera Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 February 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2011PTC072493. Its GSTIN is 36AAECC2717R1ZA (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sabitha Kalluri and Ravi Mahanthi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹22.48 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹97.75 Lakh (net margin 4.3%) and EBITDA of ₹1.38 Cr (EBITDA margin 6.2%). Revenue has grown at a compounded annual rate (CAGR) of 15% over five years.
The company is associated with 1 brand: Celera Pharma.
Celera Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0059628). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website celerapharma.in.
Company details
CIN history
Celera Pharma has one previous CIN (Corporate Identification Number): U24232AP2011PTC072493. The current CIN is U24232TG2011PTC072493, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2011PTC072493 | Current |
| U24232AP2011PTC072493 | Previous |
Recognitions & Rankings of Celera Pharma
Contact details
Celera Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is celerapharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressVirupaaksha Nilayam 1 Floor Pno 67, Survey No 602 & 605 Out Colony, Hyderabad, Telangana, India – 500094
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Celera Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Celera Pharma operates one associated brand: Celera Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulations in healthcare sectors including Nephrology and Cardiology. | celerapharma.in |
Business activity
The main business activity of Celera Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Celera Pharma Private Limited, buy the company report.
Financials of Celera Pharma Private Limited
FY 2024 filings availableCelera Pharma Private Limited reported revenue of ₹22.48 Cr (up 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 23% growth in the latest year. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.38 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹97.75 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.2% | ||||
| Net Profit Margin | 4.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Celera Pharma Private Limited, buy the company report.
Board of directors of Celera Pharma Private Limited
Celera Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sabitha Kalluri | Director | 20 Sep 2014 | 12 Years 2 Months | Current |
| Ravi Mahanthi | Director | 04 Aug 2022 | 4 Years 3 Months | Current |
Peer comparison
Celera Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lucrose Pharma Private Limited | ₹22.61 Cr (FY 2025) | 10.0% | Meerut, Uttar Pradesh, India | |||
| Pharmadude Pharmacies Private Limited | ₹22.61 Cr (FY 2025) | 22.0% | Vaduthala, Kerala, India | |||
| Sethi Pharma Distributors Private Limited | ₹22.59 Cr (FY 2025) | -7.0% | Rewa, Madhya Pradesh, India | |||
| Celera Pharma Private Limitedthis company | ₹22.48 Cr (FY 2025) | ₹97.75 Lakh | 4.3% | 23.0% | Hyderabad, Telangana, India | |
| Khera Pharma Private Limited | ₹22.37 Cr (FY 2024) | -1.0% | Ropar, Punjab, India | |||
| Somatico Pharmacal Private Limited | ₹22.34 Cr (FY 2025) | 0.0% | Navi Mumbai, Maharashtra, India | |||
| Shree Signify Exim Private Limited | ₹22.26 Cr (FY 2024) | -13.0% | Nagpur, Maharashtra, India |
To see the full peer comparison of Celera Pharma Private Limited, buy the company report.
Auditor
Celera Pharma Private Limited is audited by J SRAVAN KUMAR & CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J SRAVAN KUMAR & CO | FY 2024 | 010827S |
Shareholding
The shareholding of Celera Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Celera Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Celera Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Celera Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Celera Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECC2717R1ZA | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Celera Pharma Private Limited, buy the company report.
Recent activity
Celera Pharma Private Limited has 6 board changes on record since 2014: 2 appointments and 4 cessations. The latest: Hima Sameera Kalluri ceased to be Director on 04 Aug 2022.
Frequently asked questions
Celera Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 February 2011 (15+ years old) and is registered under CIN U24232TG2011PTC072493.
Celera Pharma has 2 current directors:
- Sabitha Kalluri - Director
- Ravi Mahanthi - Director
The latest financial statements of Celera Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Celera Pharma is 36AAECC2717R1ZA, registered in Telangana.
The CIN (Corporate Identification Number) of Celera Pharma is U24232TG2011PTC072493. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Celera Pharma was incorporated on 03 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Celera Pharma by revenue are Lucrose Pharma Private Limited, Pharmadude Pharmacies Private Limited, Sethi Pharma Distributors Private Limited, Khera Pharma Private Limited, Somatico Pharmacal Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Hima Sameera Kalluri ceased to be Director on 04 Aug 2022. Ravi Mahanthi was appointed as Director on 04 Aug 2022. Sai Kappara Bharathi ceased to be Director on 27 Oct 2020. Celera Pharma has 6 board changes on record in total.
Yes, Celera Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0059628).
Celera Pharma can be reached through the website celerapharma.in. Its registered office is in Hyderabad, Telangana, India.
The registered office of Celera Pharma is at Virupaaksha Nilayam 1 Floor Pno 67, Survey No 602 & 605 Out Colony, Hyderabad, Telangana, India – 500094.

